NHS National Generic Pharmaceuticals Transition 2021_2 - Pemetrexed Solution for Infusion - LSNE

The NHS Commissioning Board (operating under the name of NHS England) · Awarded

Buyer
The NHS Commissioning Board (operating under the name of NHS England)
Status
Awarded
Country
United Kingdom
Region
England
Sector
Manufacturing
Reference
FaT-ocds-h6vhtk-02a9fe
Published
2021-07-14

Tender summary

NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed solution for infusion LSNE region.Offer reference number: CM/PHG/21/5639/00Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months)FIND A TENDER (FTS) Reference number: 2021/S 000-008845Potential periods of call-offs under the framework agreement: 24/06/2021 to 31/01/2023 (19 months) LSNE region.

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap